{"pmid":32314460,"title":"Challenges of Covid-19 Pandemic for Dermatology.","text":["Challenges of Covid-19 Pandemic for Dermatology.","SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved.","Dermatol Ther","Wollina, Uwe","32314460"],"abstract":["SARS-CoV-2 is a new corona virus responsible for the pandemic named Coronavirus Disease 2019 (COVID-19). The disease causes severe acute respiratory syndromes with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least education in dermatology for students will be temporarily not be possible in the classical settings. COVID-19, although not a skin disease by itself has an immense impact on dermatology. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Wollina, Uwe"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314460","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13430","keywords":["covid-19 pandemic","dermatology","sars-cov-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520054988800,"score":8.518259,"similar":[{"pmid":32307810,"title":"Coronavirus-Days in Dermatology.","text":["Coronavirus-Days in Dermatology.","Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved.","Dermatol Ther","Tursen, Umit","Tursen, Belma","Lotti, Torello","32307810"],"abstract":["Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Tursen, Umit","Tursen, Belma","Lotti, Torello"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307810","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13438","keywords":["covid-19","dermatology","skin"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664632501337849856,"score":395.0338},{"pmid":32298514,"title":"Non-cutaneous considerations of COVID19 for dermatology practices.","text":["Non-cutaneous considerations of COVID19 for dermatology practices.","COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID.","J Cosmet Dermatol","Ali, Faisal R","Al-Niaimi, Firas","32298514"],"abstract":["COVID19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarised by the acronym COVID."],"journal":"J Cosmet Dermatol","authors":["Ali, Faisal R","Al-Niaimi, Firas"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298514","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jocd.13444","keywords":["covid19","coronavirus","dermatology","immunosuppressants","practice management","teledermatology"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388438880256,"score":391.62164},{"pmid":32320091,"title":"Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","text":["Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.","J Eur Acad Dermatol Venereol","Gisondi, P","Piaserico, S","Conti, A","Naldi, L","32320091"],"abstract":["Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes."],"journal":"J Eur Acad Dermatol Venereol","authors":["Gisondi, P","Piaserico, S","Conti, A","Naldi, L"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320091","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16515","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664815087646408705,"score":350.98795},{"pmid":32297402,"title":"CORONAVIRUS-DAYS IN DERMATOLOGY.","text":["CORONAVIRUS-DAYS IN DERMATOLOGY.","Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved.","Dermatol Ther","TuRsen, Umit","Tursen, Belma","Lotti, Torello","32297402"],"abstract":["Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well-being of healthcare providers while providing a sufficient workforce to respond to the coronavirus disease (COVID-19) are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["TuRsen, Umit","Tursen, Belma","Lotti, Torello"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297402","week":"202016|Apr 13 - Apr 19","doi":"10.1111/dth.13421","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388223922176,"score":350.2858},{"pmid":32294265,"title":"Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).","text":["Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).","Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high-quality standards of care. The pandemic coronavirus (2019-nCoV; COVID-19) has changed the approach to all patients requiring close contact during a visit, including dermatologic consultations. In Italy, true outbreak begun in Lombardy, by February 21, 2020 with exponential contagion, surpassing China in the number of deaths.","J Eur Acad Dermatol Venereol","Atzori, L","Mugheddu, C","Addis, G","Sanna, S","Satta, R","Ferreli, C","Atzori, M G","Montesu, M A","Rongioletti, F","32294265"],"abstract":["Psoriasis is a major chronic inflammatory skin disease, affecting about 3% of the population in Italy, whose management require experienced specialists in order to guarantee high-quality standards of care. The pandemic coronavirus (2019-nCoV; COVID-19) has changed the approach to all patients requiring close contact during a visit, including dermatologic consultations. In Italy, true outbreak begun in Lombardy, by February 21, 2020 with exponential contagion, surpassing China in the number of deaths."],"journal":"J Eur Acad Dermatol Venereol","authors":["Atzori, L","Mugheddu, C","Addis, G","Sanna, S","Satta, R","Ferreli, C","Atzori, M G","Montesu, M A","Rongioletti, F"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294265","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16473","keywords":["covid-19","coronavirus pandemic","dermatology","psoriasis"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Italy","Italy","Lombardy","China","sardinia","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"_version_":1664636192581222401,"score":309.6844}]}